Across TCGA patient cohorts, OR6C75 mutation is significantly associated with the immune_cell of many other genes, with 6 significant associations in total. SKCM shows the largest number of these associations.

The most reproducible OR6C75-associated genes across cancer lineages are Erythrocytes, Endothelial cells, and HSC. Each is linked with OR6C75 in more than 1 cancer types. Because this analysis shows association rather than direction, both OR6C75-to-partner and partner-to-OR6C75 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (OR6C75→partner) and Y-score (partner→OR6C75) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
UCEC	Erythrocytes →	+0.024	+2.332	.031	.019	3	2
SKCM	Endothelial cells →	-0.034	-1.919	.014	.005	3	1
SKCM	HSC →	-0.059	-1.553	.045	.019	3	1
SKCM	Basophils →	+0.174	+1.604	.001	.011	3	1
SKCM	pro B-cells →	+0.073	+1.900	.018	.028	3	1
LUSC	Th1 cells →	+0.089	+3.026	.049	.018	3	1

Each partner links to its Q-omics profile. Showing the 6 strongest of 6 associations by consensus.

Exploration

OR6C75 survival (RNA) · tumor vs normal (RNA) · all OR6C75 data types